Hormonal Sensitivity following Endocrine Withdrawal in Hormone-Refractory Prostate Cancer

Publisher： Karger

E-ISSN： 1423-0399|65|1|28-31

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.65, Iss.1, 2000-08, pp. : 28-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TREATMENT WITH PREDNISOLONE OF HORMONE-REFRACTORY PROSTATE CANCER

By Fuse H.   Nozaki T.   Fujiuchi Y.   Mizuno I.   Nagakawa O.   Okumura A.  

Archives of Andrology, Vol. 52, Iss. 1, 2006-01 ,pp. : 35-38

Informa Healthcare

Access to resources Recommend Favorite

Role of Chemotherapy in Hormone-Refractory Prostate Cancer

By  

Urologia Internationalis, Vol. 70, Iss. 1, 2003-02 ,pp. : 1-14

Karger

Access to resources Recommend Favorite

REDISTRIBUTION OF ANDROGEN RECEPTORS IN ACQUIRED HORMONE-REFRACTORY PROSTATE CANCER CELLS

By Yu D. S.   Hsieh D. S.   Chang S. Y.  

Archives of Andrology, Vol. 52, Iss. 5, 2006-09 ,pp. : 389-395

Informa Healthcare

Access to resources Recommend Favorite

A Weekly Schedule of Docetaxel for Metastatic Hormone-Refractory Prostate Cancer

By  

Oncology, Vol. 66, Iss. 4, 2004-06 ,pp. : 281-287

Karger

Access to resources Recommend Favorite

Present Status and Perspectives in the Treatment of Hormone-Refractory Prostate Cancer

By  

Oncology, Vol. 69, Iss. 4, 2005-12 ,pp. : 273-282

Karger

Access to resources Recommend Favorite